CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed
Drug / intervention
Vitrectomyprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00000154
NCT00000154Phase 3Completed

Diabetic Retinopathy Vitrectomy Study (DRVS)

National Eye Institute (NEI)·interventional·Posted Sep 24, 1999·Updated Jun 24, 2005

In Brief

A Phase 3 clinical trial evaluating Vitrectomy for Diabetic Retinopathy and 2 related conditions. Completed.

Detailed Summary

To compare two therapies, early vitrectomy and conventional management, for recent severe vitreous hemorrhage secondary to diabetic retinopathy. Conventional management includes vitrectomy if hemorrhage fails to clear during a waiting period of 6 to 12 months or if retinal detachment involving the center of the macula develops at any time. To compare early vitrectomy and conventional management in eyes that have good vision but a poor prognosis because they are threatened with hemorrhage or retinal detachment from very severe proliferative retinopathy. To study the natural history of severe proliferative diabetic retinopathy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
Countries--
Collaborators--

Timeline

Phase 3CompletedFinished
1976197719781979198019811982198319841985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 24, 1999
Enrollment StartOct 1, 1976
TodayJul 2, 2026
Posted 26.8 years ago

Interventions

Vitrectomyprocedure